Director, Health Economics & Outcomes Research (HEOR)

• PhD, PharmD, DrPH or equivalent advanced qualification.
• Experience supporting multiple therapeutic areas.
• Experience influencing global evidence generation programmes.
• Experience representing organisations externally with senior stakeholders.

The Head of Health Economics & Outcomes Research (HEOR), UK, Ireland & Nordics provides strategic leadership for the development and execution of health economics, outcomes research and evidence-generation strategies that support optimal patient access to Bristol Myers Squibb medicines across the UK, Ireland and Nordic markets.

The role is accountable for designing and implementing integrated evidence plans across the portfolio, ensuring successful reimbursement and market access outcomes through engagement with NICE, SMC, AWMSG, NCPE and relevant Nordic HTA and payer stakeholders, including TLV (Sweden), NOMA/NorPD (Norway), Medicinrådet and regional HTA structures (Denmark), Fimea and Palko (Finland), and relevant authorities in Iceland.

Working across the product lifecycle, the role partners with Commercial, Medical, Regulatory, Government Affairs, Pricing, Global Market Access, Global HEOR and Global Medical to demonstrate the value of BMS therapies and support business growth.

As a member of the UK, Ireland & Nordics Market Access & External Affairs Leadership Team, the Head of HEOR contributes to portfolio prioritisation, launch excellence, organisational capability development and long-term access strategy.

• Act as a trusted advisor to the Head of Market Access and External Affairs and broader UK, Ireland & Nordics leadership team on the HEOR strategy for all assets, clearly articulating risks and opportunities.
• Develop and execute the UK, Ireland & Nordics HEOR strategy aligned with business objectives.
• Provide strategic leadership for value demonstration and evidence generation across priority brands and pipeline assets.
• Serve as the senior HEOR advisor to UK, Ireland & Nordics leadership team.
• Influence access and commercial strategy through evidence-based recommendations.
• Lead development and execution of reimbursement strategies for NICE, SMC, AWMSG, NCPE and Nordic HTA bodies.
• Direct preparation and review of economic evaluations and value dossiers.
• Oversee HTA evidence planning and submission readiness activities across the UK, Ireland and Nordics.
• Anticipate changes in HTA methodology and proactively adapt evidence strategies across markets.
• Ensure local evidence requirements are understood and reflected in market access plans for each Nordic country.
• Lead development and execution of HEOR evidence plans.
• Oversee local and global outcomes research initiatives.
• Ensure generation of high-quality real-world evidence supporting reimbursement and access objectives.
• Identify evidence gaps and implement plans to address them.
• Lead input into and alignment behind evidence generation plans and the stakeholder management, communication and influencing skills required for associated UK/RE/Global approvals.
• Provide HEOR leadership for launch preparation and lifecycle management.
• Support pipeline assessments and prioritisation decisions.
• Ensure evidence requirements are incorporated into launch strategies and Integrated Brand Planning processes.
• Partner with global teams to align on evidence gaps, prioritised needs and the evidence strategies and plans to address these.
• Ensure Nordic market access considerations are embedded early in launch planning.
• Build productive relationships with external experts, academic institutions and relevant healthcare stakeholders.
• Provide strategic input into consultations, policy discussions and external engagement activities where appropriate.
• Represent BMS HEOR at relevant selected industry forums and external meetings.
• Support policy and market-shaping initiatives where evidence generation is a critical success factor.
• Develop effective engagement with payer and HTA stakeholders across the UK, Ireland and Nordic markets.
• Recruit, lead and develop a high-performing HEOR organisation.
• Foster a culture of scientific excellence, innovation and accountability.
• Develop future talent and succession plans.
• Promote collaboration across UK&I, Nordics and international functions.
• Manage departmental budgets and external partnerships.
• Ensure effective allocation of HEOR resources and investments.
• Maximise value from external vendors and research collaborations.
• Degree in Health Economics, Public Health, Epidemiology, Pharmacy, Economics or a related scientific discipline.
• Extensive pharmaceutical industry experience in HEOR, Market Access, Outcomes Research or related field.
• Demonstrated leadership of successful HTA and reimbursement strategies.
• Strong knowledge of UK, Irish and Nordic healthcare systems, HTA processes and market access environments.
• Experience leading and developing high-performing teams.
• Proven success working within complex matrix organisations.
• Health economics and modelling
• Outcomes research methodologies
• Real-world evidence generation
• HTA strategy and reimbursement submissions
• Value communication and evidence synthesis
• Strategic mindset
• Enterprise leadership
• Talent development
• Change leadership
• Cross-functional collaboration
• Persuasive communication skills (face to face, in presentations and in writing)
• Commercial acumen
• Stakeholder engagement and influence
• Executive communication
• Decision making under uncertainty
• Resource prioritisation
• Achievement of positive reimbursement outcomes for priority assets.
• Successful delivery of NICE, SMC, AWMSG, NCPE and Nordic HTA submissions.
• Evidence strategies supporting timely patient access.
• Delivery of HEOR evidence plans against agreed timelines.
• Completion of priority RWE and outcomes research projects.
• Publication and dissemination of strategically important evidence.
• Effective support for launch readiness and pipeline decision making.
• HEOR contribution to achievement of UK, Ireland & Nordics access objectives.
• Strategic recommendations adopted by cross-functional teams.
• Development and retention of high-performing talent.
• Strong employee engagement and organisational health outcomes.
• Effective succession planning and capability development.
• Delivery of objectives within approved budget.
• Efficient use of external resources and partnerships.

The Head of HEOR, UK, Ireland & Nordics is expected to:

• Focus relentlessly on patients and delivering access to innovative medicines.
• Demonstrate enterprise leadership and collaboration.
• Operate with integrity, urgency, accountability, inclusion and innovation.
• Drive scientific excellence and continuous improvement.
• Build strong internal and external partnerships that advance the BMS mission.

Where you work matters - because collaboration, innovation and patient impact happen in many settings. Our roles are structured across four work models: site-essential, site-by-design, field-based and remote-by-design. The model assigned to this role is based on its core responsibilities. Learn more at https://careers.bms.com/ways-of-working.